Study different types of dry eye in Sjögren’s
Treatments studied
Part of Eyes & vision clinical trials.
This study looks at patients with Sjögren’s-related dry eye to understand how different subtypes affect tear function and eye symptoms. It may help doctors better sort out dry eye types, which can guide more tailored care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have dry eye disease that fits the TFOS DEWS II criteria.
- If you have Sjögren’s-related dry eye (pSS-DED), you also meet the 2016 ACR/EULAR criteria for Sjögren’s.
- You do not have another rheumatic or whole-body disease (besides Sjögren’s) that could also affect your tears.
- You have not had eye injury or eye surgery in the past.
- You have not used contact lenses, and you do not have other active eye problems (like infection, sudden inflammation, glaucoma, or eyelid problems).
- You are able to cooperate with and complete the required eye exams.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors find better ways to treat severe dry eye disease. Researchers will perform eye exams and ask questions to understand your condition better and optimize your care.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
This study looks at tiny particles called exosomes and genetic material (miRNA) in tears and blood to better understand dry eye and Sjögren's syndrome. It may help find new ways to diagnose or treat these conditions.
This study looks at tiny particles called exosomes in tears to find new ways to diagnose or treat Sjogren's syndrome and dry eye disease. It may help people with these conditions by learning more about what causes them.
This study tests a new treatment for dry eye disease caused by Sjögren's syndrome. It may help people who still have dry eye symptoms even when using artificial tears.
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.